Skip to evidence report

ASPC.adipocyte_capillary_interface: Studies — page 3

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,040 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 2,001–3,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for ASPC.adipocyte_capillary_interface
#Trait / studyIndividual trait IDMean IC score
2001PECAM1 levelsGCST904702062.28
2002Sleep apnea (MTAG)GCST902673622.27
2003ALB levelsGCST900187252.27
2004Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T239ECGA0002392.27
2005Varicose veins of lower extremity | circulatory systemUKBB000008952.27
2006PARK7 levelsGCST904701592.27
2007aseg rh intensity Thalamus-ProperGCST900037822.27
2008PCDH1 levelsGCST904701702.27
2009IDP dMRI TBSS L2 Superior corona radiata LGCST900041482.26
2010DTI TBSS MD Retrolenticular part of internal capsule RGCST903845922.26
2011IL17D levelsGCST904695602.26
2012CD55 levelsGCST904686372.26
2013ABHD14B/CCS ratioGCST903131392.26
2014METAP1D/PLXNA4 ratioGCST903154272.26
2015ADAMTS13 levelsGCST904682222.26
2016Cyst of kidney, acquired (PheCode 586.2)GCST904761332.26
2017Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T78ECGA0000782.25
2018DTI autoptx L3 atr l tractGCST903851952.25
2019DTI autoptx FA slf l tractGCST903851332.25
2020HS1BP3 levelsGCST904694772.25
2021Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T424ECGA0004242.24
2022CD69 levelsGCST904686432.24
2023IDP dMRI TBSS L2 External capsule LGCST900041562.24
2024IDP T1 FAST ROIs V cerebellum XGCST900025882.24
2025ALB levelsGCST904971012.24
2026Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T108ECGA0001082.24
2027HSDL2 levelsGCST904694852.24
2028Omega-6 fatty acids to total fatty acids percentageGCST905025402.24
2029T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 13)GCST903205762.24
2030IDP T1 FAST ROIs R cerebellum VIIIbGCST900025832.24
2031aparc-Desikan lh area pericalcarineGCST900030932.23
2032Middle diffusion tensor imaging along the perivascular space indexGCST904555442.23
2033Frequency of light DIY in last 4 weeks | Physical activityUKBB000002642.23
2034Pain type(s) experienced in last month - Headache | PainUKBB000006272.23
2035NID1/NID2 ratioGCST903155412.23
2036CLMP/GFRA1 ratioGCST903141332.23
2037IDP dMRI ProbtrackX ISOVF ar rGCST900045262.23
2038CCL22/PDGFB ratioGCST903136922.23
2039Diacylglycerol_36:4_[M+H-H2O]1+ levelsGCST900601882.23
2040Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T21ECGU0000212.22
2041Operation year/age first occurred | OperationsUKBB000005702.22
2042Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T89ECGU0000892.22
2043Total testosterone levelsGCST900121142.22
2044Diacylglycerol (18:0_18:1) levelsGCST900247142.22
2045PDGFC levelsGCST904701902.21
2046Family history of certain disabilities and chronic diseases leading to disablement | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000002362.21
2047Pulmonary fibrosisGCST900186882.21
2048ALCAM/CDH5 ratioGCST903132342.21
2049Hypopotassemia (PheCode 276.14)GCST904757552.21
2050Left-hemisphere salience/ventral attention network to left-hemisphere default mode network white-matter structural connectivityGCST903027112.21
2051IDP dMRI ProbtrackX FA str rGCST900039492.21
2052Paroxysmal supraventricular tachycardia (PheCode 427.11)GCST904759642.21
2053Sphingomyelin_40:2_[M+H]1+ levelsGCST900603522.21
2054C5 levelsGCST904685002.21
2055PODXL levelsGCST904702802.20
2056Hypertension (confirmatory factor analysis Factor 12)GCST903093462.20
2057Cholesteryl ester_18:1_[M+NH4]1+ levelsGCST900602212.20
2058CPXM1/MDK ratioGCST903142212.20
2059Biological Sibling: Coronary Artery / Coronary Heart DiseaseGCST904763702.20
2060LRP11/NECTIN2 ratioGCST903153292.19
2061EPCAM levelsGCST904691262.19
2062DAPP1 levelsGCST904689462.19
2063Paradoxical eczema in biologic-treated plaque psoriasisGCST901625502.19
2064Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T109ECGA0001092.19
2065aparc-a2009s lh area G+S-subcentralGCST900033002.19
2066Left-hemisphere dorsal attention network to right-hemisphere visual network white-matter structural connectivityGCST903026942.19
2067Bone marrow fat fraction of lumbar vertebra 1GCST906523862.19
2068Benign neoplasm of colon, rectum, anus and anal canalFING000001552.19
2069SRPK2 levelsGCST904707432.19
2070Left-hemisphere somatomotor network to left-hemisphere somatomotor network white-matter structural connectivityGCST903026692.18
2071Phospholipids in large HDL (UKB data field 23560)GCST902696572.18
2072CTF1 levelsGCST904689012.18
2073Other headache syndromesFING000010552.18
2074Arabitol/xylitol levelsGCST902000112.18
2075PLPBP levelsGCST904702602.18
2076Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T78ECGU0000782.18
2077CLEC1B/TXNDC5 ratioGCST903141052.18
2078Left ventricular end systole inferior wall thicknessGCST902785092.18
2079Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ levelsGCST900602542.18
2080High blood pressure / hypertensionGCST904752142.18
2081CCL11 levelsGCST902747642.18
2082PDCD1LG2 levelsGCST904701802.18
2083IDP dMRI TBSS MD Posterior corona radiata RGCST900040532.17
20841-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levelsGCST902006852.17
2085Heart failure and bmi 25plusFING000006032.17
2086BA-exvivo lh volume BA2GCST900028362.17
2087Takes medication for Chronic lung diseases including COPD, Emphysema and Bronchitis?GCST904752732.17
2088Hip minimal joint space widthGCST902813652.17
2089NUMB levelsGCST904701082.17
2090Testosterone | Blood biochemistryUKBB000008162.17
2091PRKAR2A levelsGCST904703272.16
2092T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 103)GCST903209222.16
2093Weight-to-muscle ratioGCST902673592.16
2094low density lipoprotein cholesterol (LDLC, minimum, inv-norm transformed)GCST904754202.16
20955alpha-pregnan-3beta,20beta-diol monosulfate (1) levelsGCST901998532.16
2096RSPO1 levelsGCST904705032.16
2097Triglycerides to phosphoglycerides ratio (UKB data field 23435)GCST902695322.16
2098IL31RA levelsGCST904695892.16
2099Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T382ECGU0003822.16
2100Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T47ECGU0000472.15
2101wg rh intensity-contrast middletemporalGCST900038412.15
2102FOLH1 levelsGCST902412722.15
2103high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed)GCST904753542.15
2104Congestive heart failureGCST904752002.15
2105CLMP/TNFRSF19 ratioGCST903141362.15
2106ING1 levelsGCST904696132.15
2107IDP dMRI TBSS ISOVF Sagittal stratum LGCST900045082.15
2108Free cholesterol in very large VLDLGCST905005812.14
2109IDP T1 FAST ROIs L planum temporaleGCST900025412.14
2110Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T299ECGU0002992.14
2111Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T46ECGA0000462.14
2112IDP dMRI ProbtrackX FA atr lGCST900039272.14
2113Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T41ECGA0000412.14
2114IDP dMRI ProbtrackX MD cst rGCST900042282.14
2115Bilirubin (E,Z or Z,E) levelsGCST902437502.14
2116Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T233ECGA0002332.13
2117aseg lh intensity Thalamus-ProperGCST900037682.13
2118Lysoalkylphosphatidylcholine (O-22:1) levelsGCST900241962.13
2119MPIG6B levelsGCST904699352.12
2120aparc-a2009s rh volume S-calcarineGCST900030422.12
2121CCL19 levelsGCST902747652.12
2122EIF2AK2 levelsGCST904690912.12
2123Eustachian tube disorders (PheCode 381.2)GCST904759042.12
2124T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82)GCST903209012.12
2125IGF2R/RNASET2 ratioGCST903151322.12
2126ALB levelsUKBB000000192.12
2127Parental longevity (both parents in top 10%)GCST0066982.12
2128X-16087 levelsGCST902005372.12
2129SLC9A3R2 levelsGCST904706662.11
2130ADGRE2/CD58 ratioGCST903131752.11
2131CXCL12 levelsGCST904689252.11
2132Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T105ECGA0001052.11
2133NIT2 levelsGCST904700512.11
2134MCFD2 levelsGCST904698732.11
2135aparc-a2009s lh area S-postcentralGCST900033632.11
2136Prescriptions - selective beta1 antagonist|beta blockerUKBB000006992.10
2137Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T302ECGU0003022.10
2138IGLL1 levelsGCST902414732.10
2139Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T8ECGA0000082.10
2140Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T381ECGU0003812.10
2141Familial combined hyperlipidemia defined by Dutch criteriaGCST901040052.10
2142Pustulosis palmaris et plantarisFING000012332.10
2143JAM2/TGFBR2 ratioGCST903152382.10
2144Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T304ECGU0003042.10
2145SPART levelsGCST904707192.10
2146Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T16ECGU0000162.09
2147Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T19ECGU0000192.09
2148TPD52L2 levelsGCST904709422.09
2149Citrate levelsGCST902434422.09
2150Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T49ECGU0000492.09
2151NTRK2 levelsGCST904700972.09
2152WASF1 levelsGCST904710672.09
2153CLU levelsGCST904687932.09
2154Early age-related macular degenerationGCST0107232.08
2155Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T316ECGA0003162.08
2156ADM/CLMP ratioGCST903131972.08
2157Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T7ECGA0000072.08
2158N-acetylalanine levelsGCST902003032.08
2159Recent feelings or nervousness or anxiety | AnxietyUKBB000007412.08
2160CLSTN2/MATN2 ratioGCST903141432.08
2161GRAP2/PTPN6 ratioGCST903149862.07
2162C1QTNF1/COL4A1 ratioGCST903135522.07
2163MINK1 levelsGCST904699092.07
2164CRYZL1 levelsGCST904688782.07
2165ICA1 levelsGCST904694972.07
2166rfMRI connectivity ICA-features 3GCST900063412.07
2167Pulse wave Arterial Stiffness index | Arterial stiffnessUKBB000007242.07
2168IDP dMRI ProbtrackX OD str lGCST900044732.07
2169Ulcerative colitisGCST904760672.07
2170YWHAQ levelsGCST904710922.06
2171Heart rate variability (corrected standard deviation of normal-to-normal intervals)GCST902812662.06
2172Nasal polyps (PheCode 471)GCST904760192.05
2173Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T393ECGA0003932.05
2174T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 79)GCST903208982.05
2175NT5C1A levelsGCST904700902.05
2176red blood cell count (RBC, mean, inv-norm transformed)GCST904763472.05
2177FABP6 levelsGCST904691782.05
2178EGFR/MEGF9 ratioGCST903146142.05
2179Waist-hip ratioGCST902786492.05
2180Conductive hearing loss (PheCode 389.2)GCST904759122.04
2181ITPA levelsGCST904696542.04
2182aparc-Desikan rh volume parstriangularisGCST900028202.04
2183Polyunsaturated fatty acids to total fatty acids percentageGCST905026442.04
2184SNAP29 levelsGCST904706922.03
2185Right ventricular end systolic volumeGCST902681182.03
2186CLEC1B/VTA1 ratioGCST903141072.03
2187Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T94ECGU0000942.03
2188Anaphylactic shock due to adverse effect of correct drug or medication properly administeredFING000000842.03
2189Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T49ECGA0000492.03
2190Triacylglycerol_46:5_[M+NH4]1+ levelsGCST900603562.03
2191CELA3A/CTRB1 ratioGCST903140112.03
2192Maximum digits remembered correctly | Numeric memoryUKBB000004302.03
2193Sphingomyelin_36:1_[M+H]1+ levelsGCST900602662.03
2194Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T395ECGA0003952.02
2195Retinal venular tortuosityGCST902703992.02
2196SOST levelsGCST904707112.02
2197ICD10 N80: EndometriosisGCST904542132.02
2198Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T361ECGU0003612.01
2199aparc-DKTatlas rh volume parsopercularisGCST900029092.01
2200Iron deficiency anaemiaFING000006992.01
2201DTI TBSS L2 Anterior corona radiata RGCST903844982.01
2202Frailty (Factor 4 - Metabolic Problems)GCST906240502.01
2203CCL21 levelsGCST904685732.01
2204Mean arterial pressure, combined automated + manual reading | Cardiovascular measurementUKBB000004372.01
2205CILP levelsGCST904687542.01
2206DTD1 levelsGCST904690452.01
2207C1QTNF5 levelsGCST904684892.01
2208Autorefraction - 3mm asymmetry angle (left) | EyesightUKBB000000602.01
2209TNFRSF8/TNFRSF9 ratioGCST903159402.01
2210DTI TBSS L2 Sagittal stratum RGCST903845062.01
2211PTPRM levelsGCST904703842.01
2212Polyunsaturated fatty acids to total fatty acids percentageGCST905021812.00
2213CD177 levelsGCST904686032.00
2214Melanocytic naevi of trunkFING000008002.00
2215Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025672.00
2216MigraineGCST904681422.00
2217Free cholesterol in very small VLDLGCST905007772.00
2218Parental longevity (combined parental attained age, Martingale residuals)GCST0066972.00
2219Phospholipids in large VLDLGCST904982432.00
2220Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T42ECGA0000422.00
2221Diacylglycerol_36:3_[M+H-H2O]1+ levelsGCST900601892.00
2222AXL/MSR1 ratioGCST903134222.00
2223Autorefraction - 6mm strong meridian angle (left) | EyesightUKBB000000772.00
2224CLEC14A levelsGCST904687662.00
2225Subjective well-beingGCST901048971.99
2226MAP2K6 levelsGCST904698521.99
2227FAM172A levelsGCST904691841.99
2228T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109)GCST903209281.99
2229Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T394ECGA0003941.99
2230IDP dMRI TBSS L1 Superior longitudinal fasciculus LGCST900041161.99
2231Mean arterial pressure, automated reading | Cardiovascular measurementUKBB000004341.99
2232Right hippocampal volume (tail)GCST902679731.98
2233Peripheral vascular diseaseGCST900861341.98
2234Sphingomyelin_40:3_[M+H]1+ levelsGCST900603481.98
2235AGT levelsGCST904682571.98
2236IL3RA levelsGCST904695961.98
2237Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T65ECGU0000651.98
2238Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T360ECGU0003601.98
2239Non-cancer illness code, self-reported - glaucoma | Medical conditionsUKBB000005111.98
2240IDP dMRI ProbtrackX L2 slf lGCST900042941.98
2241Mean arterial pressure (BMI adjusted)GCST903351691.98
2242Urine 16a-hydroxy DHEA 3-sulfate levels in chronic kidney diseaseGCST902643291.98
2243HeterophoriaFING000006201.98
2244MAPK9 levelsGCST904698571.98
2245SUMF2 levelsGCST904707841.97
2246FABP2 levelsGCST904691741.97
2247Psoriasis vulgarisGCST900186871.97
2248CLEC10A levelsGCST904687631.97
2249Diaphragmatic hernia | HerniaUKBB000001721.97
2250Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T21ECGA0000211.97
2251IDP dMRI ProbtrackX ICVF ar rGCST900043761.97
2252FAM3B/FGF19 ratioGCST903147761.97
22534-acetamidobutanoate levelsGCST902434401.97
2254PLA2G15/PRCP ratioGCST903156611.97
2255LTBP2/PDGFRA ratioGCST903153381.97
2256Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T429ECGA0004291.97
2257Mean arterial pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000004391.96
2258MCAM/NTRK3 ratioGCST903154091.96
2259DTI TBSS L3 Retrolenticular part of internal capsule RGCST903845441.96
2260Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T317ECGA0003171.96
2261LILRB4 levelsGCST904697781.96
2262aparc-DKTatlas lh area lateraloccipitalGCST900032431.96
2263T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 128)GCST903209471.96
2264wg lh intensity-contrast precuneusGCST900038161.96
2265ACVRL1/TNFRSF10B ratioGCST903131581.95
2266ITGB1BP2/STAT5B ratioGCST903152201.95
2267Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T102ECGA0001021.95
2268PLA2G10 levelsGCST904702441.95
2269Benign lipomatous neoplasmFING000001461.95
2270Total protein levelsUKBB000008261.95
2271Asphyxia and hypoxemia (PheCode 1013)GCST904755591.95
2272DTI TBSS L3 Uncinate fasciculus RGCST903845681.95
2273Fracture of radius and ulna (PheCode 803.2)GCST904762801.95
2274GoutFING000005871.95
2275Physical decline (log-difference score)GCST905658471.95
2276Free cholesterol in large VLDLGCST904981811.95
2277Lysophosphatidylethanolamine-P_20:0_[M-H]1- levelsGCST900601471.95
2278DNAJB14 levelsGCST902409521.95
2279T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 48)GCST903206111.95
2280Mean arterial pressure, automated reading | Cardiovascular measurementUKBB000004331.94
2281CREG1/SMPDL3A ratioGCST903142521.94
2282Left ventricular end systole inferolateral wall thicknessGCST902785101.94
2283Alanine transaminase (ALT, maximum, inv-norm transformed)GCST904751091.94
2284Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T112ECGU0001121.94
2285Age-related macular degeneration (whether dry or wet)FING000000471.94
2286Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T315ECGA0003151.94
22871-(1-enyl-palmitoyl)-2-linoleoyl-GPE (p-16:0/18:2) levelsGCST902000751.94
2288PGR levelsGCST904702231.94
2289PSG1 levelsGCST904703531.93
2290DTI TBSS FA Anterior corona radiata LGCST903844031.93
2291CALCOCO2 levelsGCST904685311.93
2292FURIN/IGSF3 ratioGCST903148851.93
2293DDR1 levelsGCST904689701.93
22941-(1-enyl-palmitoyl)-2-oleoyl-gpc (p-16:0/18:1) levelsGCST902000571.93
2295CXCL5 levelsGCST900004611.93
2296X-13548 levelsGCST902438211.93
2297PTX3 levelsGCST904703921.93
2298Mean arterial pressure, combined automated + manual reading | Cardiovascular measurementUKBB000004381.93
2299C2/SSC5D ratioGCST903135551.93
2300S100A4 levelsGCST904705181.92
2301Right molecular layer hippocampal volume (body)GCST902679751.92
2302PDCD1/TNFRSF8 ratioGCST903156101.92
2303C1QTNF1 levelsGCST904684881.92
2304SERPINB8 levelsGCST904705921.92
2305Mean arterial pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000004401.92
2306Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T425ECGA0004251.92
2307Ovarian cancer-related tumor marker CA 125 levelsGCST900120781.92
2308Unspecified/other endometriosisFING000014041.92
2309IDP dMRI TBSS L3 Posterior corona radiata RGCST900041971.92
2310PEBP1 levelsGCST904702051.91
2311Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T43ECGA0000431.91
2312Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T362ECGU0003621.91
2313NUDC levelsGCST904701021.91
2314Iron deficiency anemia secondary to blood loss (chronic) (PheCode 280.2)GCST904757701.91
2315Multi-trait sex scoreGCST902701181.91
2316Linoleic acid to total fatty acids percentageGCST905023331.91
2317Triacylglycerol (50:0) [NL-18:0] levelsGCST900251511.91
2318Spatial QRS-T angleGCST902463201.91
2319CSF1/LTBR ratioGCST903142871.91
2320IDP dMRI ProbtrackX ICVF unc rGCST900044011.91
2321Essential hypertension | circulatory systemUKBB000002091.91
2322Hypertension | circulatory systemUKBB000003341.91
2323Weight change compared with 1 year ago | General healthUKBB000009111.91
2324LAT2/SERPINB1 ratioGCST903152791.90
2325SPON1 levelsGCST904707311.90
2326Left-hemisphere default mode network to thalamus white-matter structural connectivityGCST903027671.90
2327MRAP levelsGCST900899101.90
2328SYAP1 levelsGCST904707921.90
2329Nephritis and nephropathy without mention of glomerulonephritis (PheCode 580.3)GCST904761151.90
2330rfMRI amplitudes (ICA100 node 27)GCST900046151.90
2331MEPE/SOST ratioGCST903154201.90
2332Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T63ECGU0000631.90
2333ASGR1/DCBLD2 ratioGCST903133641.90
2334aparc-a2009s rh area G+S-occipital-infGCST900033721.90
2335LSP1/NADK ratioGCST903153311.90
2336T1 FreeSurfer BA rh BA3b exvivo areaGCST903855501.90
2337C2/LILRB4 ratioGCST903135541.89
2338Benign neoplasm: Rectum, anus and anal canalFING000001971.89
2339Diastolic blood pressureGCST904727781.89
2340Abnormalities of forces of labourFING000000031.89
2341LTBR/TNFRSF14 ratioGCST903153401.89
2342OsteoporosisFING000009141.89
2343Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T315ECGU0003151.89
2344T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 118)GCST903206811.88
2345Plasma N-acetylhistidine levels in chronic kidney diseaseGCST902655761.88
2346ENO2/SULT1A1 ratioGCST903146691.88
2347Triglycerides in very small VLDLGCST905008731.88
2348DTI TBSS L3 Superior longitudinal fasciculus RGCST903845641.88
2349high density lipoprotein cholesterol (HDLC, maximum, inv-norm transformed)GCST904753481.88
2350Treatment/medication code - perindopril | MedicationsUKBB000008541.87
2351Phenylacetylcarnitine levelsGCST901999931.87
2352aseg global volume BrainSegGCST900025901.87
2353CCN3/COL6A3 ratioGCST903137201.87
2354SOD1 levelsGCST904707041.87
2355Total Alkenylphosphatidylcholine levelsGCST900258351.87
2356BA-exvivo rh volume BA45GCST900028571.87
2357X-11786--methylcysteine levelsGCST902436541.87
2358EIF4G1 levelsGCST904690971.87
2359Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T359ECGU0003591.87
2360Left ventricular end systole inferoseptal wall thicknessGCST902785081.87
2361STROKEFING000013361.87
2362Insomnia (PheCode 327.4)GCST904758261.87
2363CA2/PSMG3 ratioGCST903135811.86
2364SFTPA1 levelsGCST904706121.86
2365MIF/PARK7 ratioGCST903154471.86
2366CRNN levelsGCST902778901.85
2367Hypertension, essentialFING000006381.85
2368DARS1/EIF4B ratioGCST903144031.85
2369IDP dMRI ProbtrackX L3 slf lGCST900043211.85
2370wg rh intensity-contrast inferiorparietalGCST900038341.85
2371rfMRI amplitudes (ICA25 node 12)GCST900045791.85
2372ITPR1 levelsGCST904696551.85
2373Mean arterial pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB000004351.85
2374NID2 levelsGCST904700481.85
2375Mean arterial pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB000004361.84
2376NFU1 levelsGCST904700401.84
2377aparc-a2009s lh area S-calcarineGCST900033401.84
2378Forced expiratory volume in 1-second (FEV1), predicted percentage | SpirometryUKBB000002531.84
2379Cholesterol in Medium LDLGCST904987071.84
2380Left-hemisphere dorsal attention network to right-hemisphere control network white-matter structural connectivityGCST903026991.84
2381Other benign neoplasms of skinFING000009711.84
2382CD164 levelsGCST904686021.83
2383BA-exvivo rh area MTGCST900032321.83
2384P4HB/PPP1R12A ratioGCST903155911.83
2385GPI levelsGCST904693911.83
2386Left-hemisphere limbic network to thalamus white-matter structural connectivityGCST903027361.83
2387LTA4H levelsGCST904698121.83
2388Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T426ECGA0004261.83
2389Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T38ECGA0000381.83
2390Sphingomyelin_42:2_[M+OAc]1- levelsGCST900605071.83
2391aparc-a2009s rh volume G-precentralGCST900030271.83
2392FGF19/SCG2 ratioGCST903148091.82
2393Glaucoma (PheCode 365)GCST0083731.82
2394Right-hemisphere dorsal attention network to right-hemisphere control network white-matter structural connectivityGCST903028041.82
2395Cholesteryl esters in chylomicrons and extremely large VLDL (UKB data field 23485)GCST902695821.82
2396DNAJB14 levelsGCST904690111.82
2397Colon cancerGCST900118111.82
2398Left-hemisphere control network to caudate white-matter structural connectivityGCST903027531.82
2399Fractured bone site(s) - Other bones | Medical conditionsUKBB000002561.82
2400AGRN levelsGCST904682551.82
2401Total lipids in very large VLDL (UKB data field 23489)GCST902695861.82
2402X-12063 levelsGCST902436871.82
2403FOXO3 levelsGCST904692661.82
2404CASP7 levelsGCST904685471.82
2405Frontal QRS-T angleGCST902463211.82
2406IDP dMRI TBSS L3 Cingulum hippocampus RGCST900042071.81
2407DSG2 levelsGCST904690421.81
2408Average diameter for HDL particlesGCST904974541.81
2409DorsopathiesFING000004731.81
2410IDP dMRI TBSS L3 Superior longitudinal fasciculus LGCST900042121.81
2411Cancer (standard GWA)GCST902672701.81
2412ST13 levelsGCST904707511.81
2413DOK1 levelsGCST904690281.81
2414HPGDS/ITGAV ratioGCST903150801.81
2415Light smokers, at least 100 smokes in lifetime | SmokingUKBB000004071.81
2416Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)GCST902695551.80
2417Linoleic acid levelsGCST904983091.80
2418Ascending aorta distensibilityGCST902673851.80
2419LRP11/ROR1 ratioGCST903153301.80
2420RWDD1 levelsGCST904705101.80
2421T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 33)GCST903205961.80
2422FHIT/PMVK ratioGCST903148221.80
2423Central pulse pressureGCST902673871.80
2424TMSB10/ZBTB16 ratioGCST903159261.80
2425CXCL12/TIMP3 ratioGCST903143381.80
2426triglyceride (maximum, inv-norm transformed)GCST904764291.80
2427COL1A1 levelsGCST904688131.80
2428APOA4 levelsGCST904683331.80
2429Breast cancer | neoplasmsUKBB000001091.79
2430Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T308ECGA0003081.79
2431PDLIM7/SRC ratioGCST903156391.79
2432GMFG levelsGCST904693661.79
2433CD20 on IgD- CD38- B cellGCST900017551.79
2434Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T500ECGA0005001.79
2435CCL16 levelsGCST901792431.78
2436FCRL2/LY9 ratioGCST903147991.78
2437aseg rh volume choroid-plexusGCST900026461.78
2438Cholesteryl Esters to Total Lipids in Small VLDL percentageGCST904998041.78
2439Operative procedures - Fibreoptic endoscopic snare resection of lesion of colon | Summary OperationsUKBB000005791.78
2440Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T185ECGU0001851.78
2441T1 FreeSurfer a2009s lh S temporal sup areaGCST903847401.78
2442wg rh intensity-contrast inferiortemporalGCST900038351.78
2443IL6ST/MARCO ratioGCST903151671.78
2444wg rh intensity-contrast supramarginalGCST900038571.78
2445MYOC levelsGCST904228251.78
2446Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T319ECGA0003191.77
2447Cholesterol in chylomicrons and extremely large VLDL (UKB data field 23484)GCST902695811.77
2448Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T48ECGU0000481.77
2449PPP1R12A levelsGCST904703001.77
2450CTSL levelsGCST904689141.77
2451Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T428ECGA0004281.76
2452Urine andro steroid monosulfate C19H28O6S (1)* levels in chronic kidney diseaseGCST902647961.76
2453Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T79ECGU0000791.76
2454Hypertensive Heart DiseaseFING000006391.76
2455CST3/EFEMP1 ratioGCST903142921.76
2456CHCHD10 levelsGCST904687381.76
2457Sphingomyelin_41:2_[M+H]1+ levelsGCST900603831.76
2458Margaroylcarnitine (C17) levelsGCST901999291.76
2459DTI TBSS MD FornixGCST903845771.76
2460Phospholipids in very large VLDLGCST905006471.76
2461Bone marrow fat fraction of lumbar vertebra 4GCST906523891.76
2462Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T484ECGU0004841.76
2463DTI TBSS MD Superior fronto-occipital fasciculus LGCST903846151.75
2464T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 97)GCST903206601.75
2465IDP dMRI TBSS L2 External capsule RGCST900041551.75
2466WASHC3 levelsGCST904710691.75
2467Corneal edema (PheCode 364.2)GCST904758621.75
2468aparc-DKTatlas lh thickness lateraloccipitalGCST900035491.75
2469Fibroblastic disordersFING000005421.75
2470DKK1/VTA1 ratioGCST903144851.75
2471PTP4A3 levelsGCST904703751.75
2472SRC/TBL1X ratioGCST903158841.75
2473Anemia of chronic disease (PheCode 285.2)GCST904757901.75
2474Diverticulitis (PheCode 562.2)GCST904760771.75
24753-amino-2-piperidone levelsGCST902001881.75
2476Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T16ECGA0000161.75
2477Testicular hypofunction (PheCode 257.1)GCST904756971.75
2478Trunk fat-free mass | Impedance measuresUKBB000008651.75
2479aparc-pial rh area pericalcarineGCST900031941.75
2480VLDL cholesterol levelsGCST905001891.74
2481Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T430ECGA0004301.74
2482Trunk predicted mass | Impedance measuresUKBB000008661.74
2483Male-pattern baldnessGCST0066611.74
2484Hypertensive heart disease (PheCode 401.21)GCST904759251.74
2485CIAPIN1/SPARC ratioGCST903140691.74
2486IL22 levelsGCST900880661.74
2487Varicose veins of lower extremity (PheCode 454.1)GCST904760131.73
2488Other peripheral nerve disorders | neurologicalUKBB000006181.73
2489Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)GCST902695801.73
2490Hyperglyceridemia (PheCode 272.12)GCST904757241.73
2491Normotensive glaucomaFING000008921.73
2492BA-exvivo rh volume MTGCST900028601.73
2493Urine glucosaminate levels in chronic kidney diseaseGCST902651791.73
24941-linoleoyl-GPI (18:2) levelsGCST901998211.73
2495ICD10 O26.6: Liver disorders in pregnancy, childbirth and puerperiumGCST904542371.73
2496Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T316ECGU0003161.73
2497DAB2 levelsGCST904689421.72
2498IDP dMRI ProbtrackX MD cgc rGCST900042241.72
2499IDS/SMPDL3A ratioGCST903151261.72
2500IDP dMRI TBSS MD Superior corona radiata RGCST900040511.72
2501DTI TBSS FA Splenium of corpus callosumGCST903843841.72
2502Acute renal failureFING000000301.72
2503CCL13/CCL2 ratioGCST903136751.72
2504Volume of left basal nucleusGCST904748771.72
2505Myocardial fractal dimension (slice 7)GCST900002931.72
2506APPL2 levelsGCST904683431.72
2507Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T427ECGA0004271.72
2508MPI levelsGCST904699361.72
2509Diastolic blood pressureGCST904727791.72
2510HLA-DRA levelsGCST904694581.71
2511Triglycerides in very large VLDL (UKB data field 23494)GCST902695911.71
2512Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)GCST902695781.71
2513Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T390ECGA0003901.71
2514CD200 levelsGCST904686061.71
2515MINDY1 levelsGCST904699081.71
2516Coxarthrosis, primary, with hip surgeryFING000003641.71
2517SMOC2 levelsGCST904706831.71
2518high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed)GCST904753501.71
2519Normal-pressure hydrocephalusFING000008911.70
2520Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T110ECGA0001101.70
2521Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T108ECGU0001081.70
2522Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T236ECGU0002361.70
2523IL12B levelsGCST902747981.70
2524Facial ageing | Sun exposureUKBB000002331.70
2525ADGRE2/B4GALT1 ratioGCST903131741.70
2526PRDX5 levelsGCST904703181.70
2527Left-hemisphere default mode network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027631.70
2528Octadecenedioylcarnitine (C18:1-DC) levelsGCST901999701.70
2529ICD10 O20: Haemorrhage in early pregnancyGCST904542351.70
2530Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T391ECGA0003911.70
2531CD276 levelsGCST904686141.70
2532OtosclerosisGCST901295751.70
2533PLXNA4/SKAP2 ratioGCST903156851.70
2534ANXA3 levelsGCST904683181.69
2535CD93 levelsGCST904686561.69
2536DTI TBSS L3 Superior longitudinal fasciculus LGCST903845651.69
2537Mean volume of bilateral amygdalaGCST904749921.69
2538Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T318ECGA0003181.69
2539Gastroduodenal ulcerFING000005651.69
2540Left hippocampal volumeGCST902679521.69
2541FGF5 levelsGCST904692261.68
2542Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T318ECGU0003181.68
25431-palmitoyl-2-oleoyl-GPE (16:0/18:1) metabolite levelGCST906164031.68
2544Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T100ECGA0001001.68
2545Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T105ECGU0001051.68
2546TXNDC5 levelsGCST904709911.68
2547EFEMP1 levelsGCST904690781.68
2548Chronic pancreatitisGCST900186011.68
2549Serum phosphate levelsGCST900259481.68
2550IGFBP4 levelsGCST904695301.68
2551AK2 levelsGCST904682701.68
2552TFPI2 levelsGCST904708381.68
2553Female infertility, cervigal, vaginal, other or unspecified originFING000005381.68
2554Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T392ECGA0003921.68
2555CRTAC1 levelsGCST904688701.68
2556rfMRI connectivity (ICA100 edge 495)GCST900053481.67
2557PEPD levelsGCST904702091.67
2558PPP1R14D levelsGCST904703031.67
2559ITGAM levelsGCST904696381.67
2560Total cerebellar volume (excluding Crus I vermis)GCST900201901.67
2561SKAP2/VSIR ratioGCST903158491.67
2562FYN levelsGCST902432001.67
2563aparc-Desikan lh volume supramarginalGCST900027981.67
2564Triglycerides | Blood biochemistryUKBB000008611.67
2565Saturated fatty acids to total fatty acids percentageGCST905026971.67
2566Separation of retinal layers (serosa)FING000012921.67
2567Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T20ECGU0000201.67
2568TIMP1 levelsGCST904708691.67
2569ICD10 N97.8: Female infertility of other originGCST904542251.66
2570Lumbar disc prolapseFING000007351.66
2571MMP10 levelsGCST900120501.66
2572EGF/MGLL ratioGCST903146101.66
2573Mean bone marrow fat fraction of thoracic vertebrae 8-12GCST906523851.66
2574SUGT1 levelsGCST904707801.66
2575YTHDF3 levelsGCST904710911.66
2576Posterior thigh muscle volumeGCST902673531.66
2577NXF1 levelsGCST902421491.65
2578CD3 on Terminally Differentiated CD4+ T cellGCST900018441.65
2579LGALS1 levelsGCST904697591.65
2580POLR2F levelsGCST904702831.65
2581Total protein levelsGCST904681051.65
2582Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T20ECGA0000201.65
2583Left-hemisphere visual network to left-hemisphere control network white-matter structural connectivityGCST903026531.65
2584Right-hemisphere visual network to pallidum white-matter structural connectivityGCST903027841.64
2585CD69/SCARF1 ratioGCST903138851.64
2586Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T309ECGA0003091.64
2587DTI autoptx FA fmi tractGCST903851231.64
2588Ascites (non malignant) (PheCode 572)GCST904760901.64
2589Hip fractureGCST901612401.64
2590Macular puckerFING000007451.64
2591FADD levelsGCST904691801.64
2592CLMP levelsGCST904687831.64
2593Back pain | symptomsUKBB000000841.64
2594Cholesteryl ester (16:2) levelsGCST900252381.64
2595Concentration of very large VLDL particles (UKB data field 23488)GCST902695851.64
2596T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6)GCST903205691.64
2597MET/PTPRF ratioGCST903154351.64
2598STK24 levelsGCST904707661.64
2599Non-cancer illness code, self-reported - gastro-oesophageal reflux (gord) / gastric reflux | Medical conditionsUKBB000005101.64
2600Right-hemisphere default mode network to caudate white-matter structural connectivityGCST903028451.64
2601CD99 levelsGCST904686581.64
2602KITLG/PLTP ratioGCST903152521.63
2603Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T155ECGA0001551.63
2604IDP T1 FAST ROIs L supracalc cortexGCST900025431.63
2605Obstructive chronic bronchitis (PheCode 496.21)GCST904760301.63
2606IL15RA levelsGCST904695551.63
2607ErysipelasFING000005181.63
2608ROR1 levelsGCST904704921.63
2609ACVRL1/SCARB2 ratioGCST903131571.63
2610MPIG6B/PDGFB ratioGCST903154821.63
2611PPP1R14A levelsGCST904703021.63
2612COPD-related respiratory insufficiencyFING000003521.62
2613TIMM8A levelsGCST904708681.62
2614GCC1 levelsGCST904693151.62
2615aparc-pial lh area supramarginalGCST900031711.62
2616Non-HDL cholesterol levelsGCST902396691.62
2617Free Cholesterol to Total Lipids in Very Large HDL percentageGCST905003971.62
2618ALDH1A1/CA2 ratioGCST903132431.62
2619IDP dMRI ProbtrackX ISOVF unc rGCST900045511.62
2620Total cholesterol response to statins (relative logarithmic difference)GCST904556081.62
2621GDNF levelsGCST902747921.62
2622SPINK5 levelsGCST904707241.61
2623APRT/MIF ratioGCST903133361.61
2624BTN2A1/LILRB4 ratioGCST903135461.61
2625X-21829 levelsGCST902005851.61
2626aparc-pial rh area parsopercularisGCST900031911.61
2627Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T183ECGU0001831.61
2628ATOX1/SNAP29 ratioGCST903133741.61
2629high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed)GCST904753521.61
2630IDP dMRI ProbtrackX MD slf rGCST900042411.60
2631Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T11ECGA0000111.60
2632Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T483ECGU0004831.60
2633DXO levelsGCST904690551.60
2634Breast cancer [female] | neoplasmsUKBB000001081.60
2635aparc-a2009s lh volume S-subparietalGCST900029951.60
2636CFI levelsGCST902407821.60
2637Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T301ECGU0003011.60
2638Body fat percentageGCST0070641.60
2639Placental weight (maternal genotype, adjusted for sex and gestational age)GCST902751901.60
2640Treatment or medication use - amlodipine (UKB data field 20003_1140879802)GCST900421951.60
2641IDP dMRI TBSS L1 Cerebral peduncle RGCST900040891.60
2642NAA80 levelsGCST904699901.59
2643HSPB1 levelsGCST901793171.59
26441-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) levelsGCST902000651.59
2645HNRNPK levelsGCST904694691.59
2646Offspring birth weightGCST0053141.59
2647DTI autoptx L1 cst r tractGCST903851481.58
2648CDC27 levelsGCST904686641.58
2649Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T358ECGU0003581.58
2650PPP1R2 levelsGCST904703041.58
2651COL6A3/NBL1 ratioGCST903141761.58
2652IDP dMRI ProbtrackX MD atr rGCST900042221.58
2653DBI levelsGCST904689491.58
2654Total lipids in large HDL (UKB data field 23559)GCST902696561.58
2655CERT levelsGCST904687171.58
2656Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T12ECGA0000121.58
2657T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 79)GCST903206421.58
2658Degree of unsaturationGCST905022331.58
2659ALPI levelsGCST904682851.58
2660PTGR1 levelsGCST904703701.57
2661Abnormal heart sounds (PheCode 396)GCST904759161.57
2662RGMB/SMOC2 ratioGCST903157701.57
2663CBLN4/RET ratioGCST903136601.57
2664Phospholipid levels in large HDLGCST900928521.57
2665CASP3 levelsGCST904685451.57
2666Biliary atresiaGCST902964841.57
2667Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T68ECGA0000681.57
2668Skin color (cheek, B value)GCST905027791.57
2669X-12510--2-aminooctanoic acid levelsGCST902437481.57
2670TREML1 levelsGCST904709611.57
2671MGMT levelsGCST904699021.57
2672PAK4 levelsGCST904701501.57
2673Average diameter for VLDL particles (UKB data field 23431)GCST902695281.57
2674Abscess of anal and rectal regionsFING000000051.57
2675Volume of left medial nucleusGCST904748921.56
2676aparc-pial lh area lateraloccipitalGCST900031511.56
26771-(1-enyl-palmitoyl)-2-linoleoyl-GPC (p-16:0/18:2) levelsGCST902000601.56
2678Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T383ECGU0003831.56
2679Medication use (beta blocking agents)GCST900187661.56
2680Retention of urine (PheCode 599.2)GCST904761501.56
2681Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T93ECGU0000931.56
2682GFRA3/LAYN ratioGCST903149261.56
2683High density lipoprotein cholesterol levelsGCST902786351.56
2684Low hand grip strength (60 years and older) (FNIH)GCST900075291.56
2685NFE2 levelsGCST904700351.56
2686Nonalcoholic fatty liver disease in overweight individuals (25<=BMI<=30)GCST902750471.56
2687AKT3 levelsGCST904682781.56
2688GAL levelsGCST904693001.55
2689wg lh intensity-contrast insulaGCST900038261.55
2690CDH3/NECTIN4 ratioGCST903139521.55
2691Treatment/medication code - lisinopril | MedicationsUKBB000008501.55
2692Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T36ECGA0000361.55
2693ASAH2 levelsGCST904683741.55
2694IDP dMRI TBSS FA Retrolenticular part of internal capsule LGCST900038981.55
2695Metabolic syndromeGCST904444891.55
2696aparc-a2009s lh volume G-oc-temp-med-LingualGCST900029461.55
2697IDP dMRI TBSS FA Superior corona radiata LGCST900039021.55
2698MB levelsGCST904698691.55
2699Left ventricular end diastole inferoseptal wall thicknessGCST902785141.55
2700Left-hemisphere default mode network to putamen white-matter structural connectivityGCST903027691.55
2701IDP dMRI TBSS ICVF Fornix cres+Stria terminalis LGCST900043661.54
2702Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T86ECGA0000861.54
2703Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T186ECGU0001861.54
2704CPQ levelsGCST904688461.54
2705IDP dMRI TBSS MD Superior longitudinal fasciculus RGCST900040671.54
2706DTI autoptx MD str r tractGCST903852441.54
2707T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86)GCST903209051.54
2708Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)GCST902695791.54
2709DEFB4A or DEFB4B levelsGCST904689841.54
2710IGFBP7 levelsGCST904695321.54
2711Placental weight (maternal genotype, adjusted for sex)GCST902751981.54
2712CORO1A levelsGCST904688321.54
2713FTCD levelsGCST904692741.54
2714PDGFB/TIMP3 ratioGCST903156311.54
2715Esophagitis, GERD and related diseases | digestiveUKBB000002081.54
2716PIBF1 levelsGCST904702311.54
2717CD99/MMP3 ratioGCST903139281.53
2718Degree of unsaturationGCST905027341.53
2719KRT8 levelsGCST904697201.53
2720Monounsaturated fatty acids to total fatty acids percentage (UKB data field 23454)GCST902695511.53
2721ADAM22 levelsGCST904682181.53
2722Mean volume of bilateral amygdalaGCST904749011.53
2723T1 FreeSurfer DKT rh insula areaGCST903843171.53
2724MED18 levelsGCST904698801.53
2725DCN levelsGCST904689561.53
2726Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T72ECGA0000721.53
2727Breast cancerGCST0072361.53
2728Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T317ECGU0003171.53
2729SIGLEC9 levelsGCST904706371.53
2730Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T52ECGU0000521.53
2731O-sulfo-l-tyrosine levelsGCST902436231.52
2732Triglyceride to HDL cholesterol ratioGCST902959501.52
2733CIAPIN1 levelsGCST904687531.52
2734aparc-a2009s lh volume G-postcentralGCST900029521.52
2735ABL1/CC2D1A ratioGCST903131481.52
2736Calculus of lower urinary tract (PheCode 594.2)GCST904761461.52
2737CTSO levelsGCST904689151.52
2738Gut microbiota abundance (k_Bacteria.p_Bacteroidetes.c_Bacteroidia.o_Bacteroidales.f_Rikenellaceae)GCST900276681.52
2739BOLA2 or BOLA2B levelsGCST904684601.52
2740RABGAP1L levelsGCST904704161.52
2741Polyunsaturated fatty acids to total fatty acids percentageGCST905026491.52
2742MSTN levelsGCST904699531.52
2743Gut microbiota abundance (k_Bacteria.p_Bacteroidetes.c_Bacteroidia.o_Bacteroidales.f_Rikenellaceae.g_Alistipes)GCST900277011.51
2744aseg lh intensity CaudateGCST900037691.51
2745rfMRI connectivity (ICA100 edge 614)GCST900054671.51
2746CLEC1B/VSIR ratioGCST903141061.51
2747AIDA levelsGCST904682651.51
2748Miserableness | Mental healthUKBB000004781.51
2749Volume of left anterior amygdaloid areaGCST904748711.51
2750IDP dMRI ProbtrackX ICVF ar lGCST900043751.51
2751Excessive scarringGCST904833681.51
2752Nontoxic multinodular goiter | endocrine/metabolicUKBB000005281.51
2753aparc-a2009s lh thickness S-cingul-MarginalisGCST900036481.51
2754PDGFA/SPARC ratioGCST903156201.51
2755RABEP1 levelsGCST904704141.50
2756IDP dMRI ProbtrackX L2 cst lGCST900042811.50
2757CCL22 levelsGCST902404901.50
2758Right-hemisphere visual network to caudate white-matter structural connectivityGCST903027821.50
2759Triglyceride to phosphoglyceride ratioGCST904999961.50
2760Omega-6 fatty acids levelsGCST904991701.50
2761MYDGF levelsGCST904699721.50
2762DTI TBSS L2 Posterior thalamic radiation RGCST903845041.50
2763rfMRI connectivity (ICA100 edge 961)GCST900058141.49
276421-hydroxypregnenolone disulfate levelsGCST901998491.49
2765aparc-a2009s lh volume G+S-subcentralGCST900029281.49
2766IDP T1 FAST ROIs V cerebellum VIIIbGCST900025821.49
2767IDP dMRI TBSS MD Superior corona radiata LGCST900040521.49
2768CPPED1 levelsGCST904688451.49
2769SMPD1 levelsGCST904706841.49
2770CD69/TIA1 ratioGCST903138881.49
2771CNST/PRKAR1A ratioGCST903141611.49
2772Phospholipids to Total Lipids in Large HDL percentageGCST904978631.49
2773Cereal type: Biscuit cereal (e.g. Weetabix) (UKB data field 1468_2)GCST901329691.48
2774RHOC/TBCC ratioGCST903157751.48
2775IDP dMRI TBSS L1 Sagittal stratum RGCST900041051.48
2776FYB1/PPP1R12A ratioGCST903149131.48
2777Lysoalkylphosphatidylcholine (O-24:0) levelsGCST900241971.48
2778Cardiac pacemaker in situ (PheCode 426.91)GCST904759601.48
2779ERP29 levelsGCST904691491.48
2780Loud music exposure frequency | HearingUKBB000004101.48
2781Phospholipids to Total Lipids in Very Small VLDL percentageGCST905008561.48
2782KeratoconusFING000007091.48
2783Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T238ECGU0002381.48
2784T1 CAT volume R TemporalFusiformCortexposteriordivisionGCST903840751.47
2785aparc-a2009s rh volume S-front-infGCST900030501.47
2786Mean bone marrow fat fraction of lumbar vertebrae 1-5GCST906523911.47
2787Polyunsaturated fatty acids to saturated fatty acids ratioGCST905021601.47
2788Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T389ECGA0003891.47
2789Retinoschisis and retinal cysts (PheCode 361.2)GCST904758461.47
2790Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T320ECGA0003201.47
2791wg rh intensity-contrast precuneusGCST900038511.47
2792Phosphatidylcholine_34:3_[M+H]1+/Phosphatidylethanolamine_37:3_[M+H]1+/Phosphatidate_39:4_[M+NH4]1+ levelsGCST900602981.47
2793Alkaline phosphatase | Blood biochemistryUKBB000000271.47
2794Primary Raynaud’s phenomenonGCST902717141.47
2795Diacylglycerol_34:2_[M+H-H2O]1+ levelsGCST900601781.46
2796Forced expiratory volume in 1 second FEV1 Z score (UKB data field 20256)GCST904681661.46
2797TIA1 levelsGCST904708621.46
2798IDP dMRI TBSS MO Anterior corona radiata RGCST900039741.46
2799CRTAM/TNFRSF9 ratioGCST903142801.46
2800wg rh intensity-contrast isthmuscingulateGCST900038361.46
2801Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T312ECGA0003121.46
2802Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T156ECGA0001561.46
2803Operation code - bunion/hallus valgus surgery | OperationsUKBB000005511.46
2804BA-exvivo lh thickness MTGCST900035241.46
2805Left-hemisphere default mode network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903027621.46
2806IDP dMRI TBSS L2 Posterior corona radiata LGCST900041501.46
2807Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T13ECGA0000131.45
2808Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T48ECGA0000481.45
2809IDP dMRI TBSS OD Posterior corona radiata RGCST900044281.45
2810Succinoyltaurine levelsGCST902002351.45
2811T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 65)GCST903206281.45
2812ADGRE2 levelsGCST904682371.45
2813IDP dMRI TBSS L3 Superior longitudinal fasciculus RGCST900042111.45
2814Phosphatidylcholine-O_40:6_[M+H]1+/Phosphatidylcholine-P_40:5_[M+H]1+ levelsGCST900604201.45
2815Average diameter for HDL particlesGCST900928281.45
2816RBM17 levelsGCST904704341.45
2817FCRL6/GZMA ratioGCST903148061.45
2818IDP T1 FAST ROIs R cerebellum VGCST900025651.45
2819ADGRE5/VCAM1 ratioGCST903131841.45
2820SWAP70 levelsGCST902429311.45
2821Biological Father: Coronary Artery / Coronary Heart DiseaseGCST904752411.45
2822MITD1/SNX9 ratioGCST903154541.44
2823TOMM20 levelsGCST904709311.44
2824Left-hemisphere salience/ventral attention network to right-hemisphere control network white-matter structural connectivityGCST903027171.44
2825Phospholipids in very large VLDL (UKB data field 23490)GCST902695871.44
2826rfMRI connectivity ICA-features 2GCST900063401.44
2827Other septicaemiaFING000010971.44
2828MMP3 levelsGCST904699201.44
2829Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T97ECGU0000971.44
2830NAAA levelsGCST904699911.44
2831aparc-a2009s lh area G-pariet-inf-SupramarGCST900033221.44
2832ARHGAP25 levelsGCST902426511.44
2833FUT3 or FUT5 levelsGCST904692801.44
2834EGF levelsGCST904690861.44
2835IRAK4 levelsGCST904696281.44
2836IDP T1 FAST ROIs R parietal operc cortexGCST900025361.44
2837CXCL17/SFTPA2 ratioGCST903143411.44
2838COL9A1 levelsGCST904688221.44
2839Whole body fat-free mass | Impedance measuresUKBB000009151.44
2840Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T179ECGU0001791.44
2841IDP dMRI TBSS MD Sagittal stratum RGCST900040571.44
2842FUT3 levelsGCST902412161.43
2843ALOX15B levelsGCST906175471.43
2844IDP dMRI ProbtrackX ICVF ilf lGCST900043891.43
28451-palmitoyl-2-linoleoyl-gpc (16:0/18:2) levelsGCST902003301.43
2846MMP8/PGLYRP1 ratioGCST903154651.43
2847Congenital lactase deficiencyFING000003291.43
2848Suicide or other Intentional self-harmFING000013451.43
2849CTHRC1 levelsGCST904689021.43
2850Free cholesterol to total lipids in medium HDL percentage (UKB data field 23642)GCST902697391.43
2851F3 levelsGCST900120141.43
2852FURIN/INHBC ratioGCST903148861.43
2853T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 119)GCST903209381.43
2854Cholesterol in Small LDLGCST904995591.43
2855Trigger fingerGCST901049071.43
2856PAXX levelsGCST904701611.43
2857Other abnormal uterine and vaginal bleedingFING000009191.42
2858Takes medication for high blood pressure?GCST904752161.42
2859Illnesses of father - Lung cancer | Family historyUKBB000003441.42
2860CystitisFING000003761.42
2861T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 95)GCST903206581.42
2862DKK1 levelsGCST900120601.42
2863GRAP2 levelsGCST904693991.42
2864Whole body water mass | Impedance measuresUKBB000009161.42
2865LY6D/NECTIN4 ratioGCST903153441.42
2866BA-exvivo rh thickness V1GCST900035361.42
2867Principal component-derived dietary pattern 14GCST901330191.42
2868CLEC1B levelsGCST904687681.42
2869Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T217ECGU0002171.41
2870Bone marrow fat fraction of thoracic vertebra 11GCST906523831.41
2871TBC1D23 levelsGCST904708101.41
28725alpha-pregnan-3beta,20alpha-diol disulfate levelsGCST901998381.41
2873Triacylglycerol (54:2) [NL-18:0] levelsGCST900251751.41
2874Androstenediol (3alpha, 17alpha) monosulfate (3) levelsGCST901998561.41
2875GTPBP2 levelsGCST904694171.41
2876AP1G2 levelsGCST904683231.41
2877CELA3A/CPB1 ratioGCST903140101.41
2878ASRGL1 levelsGCST904683791.40
2879TNFRSF14/TNFRSF1A ratioGCST903159351.40
2880Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T251ECGU0002511.40
2881Triacylglycerol_51:4_[M+NH4]1+ levelsGCST900604911.40
2882CASP8/RILP ratioGCST903136571.40
2883DTI autoptx FA ilf r tractGCST903851271.40
2884RGS10 levelsGCST904704651.40
2885FCGR3B levelsGCST904692021.40
2886Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T237ECGU0002371.40
2887Free cholesterol in chylomicrons and extremely large VLDL (UKB data field 23486)GCST902695831.40
2888CLEC1A/GPR37 ratioGCST903140841.40
2889Urine GlcNAc sulfate conjugate of C21H34O2 steroid** levels in chronic kidney diseaseGCST902651751.40
2890Benign neoplasm: ColonFING000001711.40
2891Ulcerative colitisGCST904681521.40
2892NTF3 levelsGCST904700941.40
2893IDP dMRI ProbtrackX L3 slf rGCST900043221.40
2894Liver enzyme levels (alkaline phosphatase)GCST900134061.40
2895Phospholipids in large VLDL (UKB data field 23497)GCST902695941.40
2896Other forms of systemic lupus erythematosusFING000010511.40
2897DTI autoptx L3 unc r tractGCST903852191.40
2898aparc-a2009s rh area G-cingul-Post-ventralGCST900033801.39
2899FCN1 levelsGCST906185651.39
2900RAB27B levelsGCST904704051.39
2901Average diameter for HDL particles (UKB data field 23433)GCST902695301.39
2902CD55/ITGB1 ratioGCST903138461.39
2903IDP dMRI ProbtrackX L1 atr lGCST900042481.39
2904Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T384ECGU0003841.39
2905Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T96ECGU0000961.38
2906IDP dMRI TBSS L1 Superior corona radiata RGCST900040991.38
2907ARHGAP1 levelsGCST904683521.38
2908RNF41 levelsGCST904704851.38
2909PTN levelsGCST904703741.38
2910Cholesteryl Esters to Total Lipids in Large HDL percentageGCST904977631.38
2911aseg rh volume CaudateGCST900026381.38
2912Cholesteryl Esters to Total Lipids in Very Large VLDL percentageGCST905005691.38
2913CD69/SNAP23 ratioGCST903138861.38
2914DUT levelsGCST904690541.38
2915Cholesterol levels in very small VLDLGCST905007121.38
2916Alkaline phosphatase (UKB data field 30610)GCST904680601.38
2917FKBP14 levelsGCST904692411.37
2918Phosphatidylcholine-O_33:3_[M+H]1+/Phosphatidylcholine-P_33:2_[M+H]1+/Phosphatidylethanolamine-O_36:3_[M+H]1+ levelsGCST900602611.37
2919TMSB10 levelsGCST904708941.37
2920TNFSF11 levelsGCST904709181.37
2921CMIP levelsGCST904687951.37
2922T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 8)GCST903208271.37
2923Volume of left paralaminar nucleusGCST904748951.37
2924IGFBP6/MFAP5 ratioGCST903151351.37
2925NID1/TIMP3 ratioGCST903155431.37
2926Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T385ECGU0003851.36
2927Total lipids in very large VLDLGCST905006071.36
2928CFB levelsGCST904687231.36
2929Non-cancer illness code, self-reported - osteoarthritis | Medical conditionsUKBB000005211.36
2930HLA-E levelsGCST904694591.36
2931PDLIM5 levelsGCST904701971.36
2932Average diameter for VLDL particlesGCST905002791.36
2933NEXN levelsGCST904700301.36
2934Concentration of very large VLDL particlesGCST905006281.36
2935Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T314ECGA0003141.36
2936MANF levelsGCST904698461.36
2937PRDX3 levelsGCST904703171.35
2938aparc-Desikan lh thickness lateraloccipitalGCST900034551.35
2939Bone marrow fat fraction of thoracic vertebra 9GCST906523811.35
2940high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed)GCST904753561.35
2941PRKRA levelsGCST904703311.35
2942Abdominal subcutaneous adipose tissueGCST902673471.35
2943EVI5 levelsGCST904691581.35
2944Cholesterol to Total Lipids in Large HDL percentageGCST904977301.35
2945MOCS2 levelsGCST904699281.35
2946Visceral adipose tissueGCST902673571.35
2947T1 FreeSurfer BA lh V2 exvivo thicknessGCST903855291.35
2948NOTCH1 levelsGCST904700651.35
2949IDP dMRI TBSS L2 Anterior corona radiata RGCST900041451.35
2950IL18R1 levelsGCST902416071.35
2951Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T126ECGA0001261.35
2952Atopic dermatitisGCST900185641.35
2953PILRB levelsGCST904702371.35
2954Diastolic blood pressure (BMI unadjusted)GCST903351641.35
2955Triglycerides x low social support interaction (2df test)GCST905706811.35
2956EPO/TFRC ratioGCST903146841.35
2957BID levelsGCST904684441.35
2958Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T326ECGA0003261.35
2959Phosphatidylcholine_34:1_[M+H]1+/Phosphatidylethanolamine_37:1_[M+H]1+/Phosphatidate_39:2_[M+NH4]1+ levelsGCST900603071.35
2960Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T357ECGU0003571.34
2961aparc-Desikan rh volume cuneusGCST900028051.34
2962MSRA/SNAP29 ratioGCST903155001.34
2963aparc-a2009s lh area S-oc-middle+LunatusGCST900033531.34
2964DCTD levelsGCST904689571.34
2965P4HB levelsGCST904701401.34
2966Glutamine levelsGCST900928181.34
2967S100A16 levelsGCST904705161.34
2968DTI TBSS MD Anterior corona radiata RGCST903845941.34
2969IDP dMRI ProbtrackX FA ar lGCST900039251.34
2970Volume of right paralaminar nucleusGCST904750481.34
2971Right ventricular end systolic volumeGCST901345891.34
2972Benign neoplasm of other and unspecified endocrine glandsFING000001591.34
2973CDKN1A levelsGCST904686841.34
2974Breast cancer (PheCode 174)GCST904356001.34
2975APRT/PSME1 ratioGCST903133381.34
2976IDP dMRI TBSS MD Uncinate fasciculus LGCST900040721.33
2977Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)FING000007511.33
2978BCL2L2 levelsGCST904220771.33
2979Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T66ECGU0000661.33
2980aseg global volume BrainSegNotVentSurfGCST900025921.33
2981AZU1/MPO ratioGCST903134251.33
2982Diffuse idiopathic skeletal hyperostosis flow scoreGCST901345321.33
2983IDP dMRI TBSS ICVF Sagittal stratum LGCST900043581.33
2984CRKL/FIS1 ratioGCST903142661.33
2985Triacylglycerol_50:5_[M+NH4]1+ levelsGCST900604631.33
2986Plasma N-acetyltaurine levels in chronic kidney diseaseGCST902656001.33
2987Carboplatin drug response (IC50)GCST900117831.33
2988IDP dMRI ProbtrackX MD ptr rGCST900042391.33
2989T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 100)GCST903209191.33
2990SRP14 levelsGCST904707421.33
2991BAG3 levelsGCST904684161.33
2992DCTN1/ERBIN ratioGCST903144291.32
2993Hippocampal left GC-ML-DG volume (head)GCST902679461.32
2994STAB2 levelsGCST904707551.32
2995Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T240ECGA0002401.32
2996CLEC14A/EPHB4 ratioGCST903140791.32
2997aparc-Desikan lh area supramarginalGCST900031031.32
2998Phospholipids to Total Lipids in Very Large VLDL percentageGCST905006551.32
2999Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T226ECGU0002261.32
3000RWDD1/SUMF2 ratioGCST903157951.32